Form 4 for NVAX NOVAVAX INC
Accepted 2025-01-02 00:00:00 ET · period of report 2024-12-24 · accession 0001593968-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-01-02 | 2024-12-24+ | NVAX | YOUNG JAMES F | Dir | S - Sale | $8.22 | -10.0K | 57.2K | -15% | -$82.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | S | D | 5,400 | $8.00 | 51,760 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-24 | S | D | 4,600 | $8.48 | 57,160 | D | — | — |